Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01ED01	XALKORI	B	Crizotinib - 250mg	250mg	Capsule	347,644,061 L.L
P02CA01	VERMOX	B	Mebendazole - 100mg/5ml	100mg/5ml	Suspension	223,078 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 1mcg	1mcg	Capsule	3,735,882 L.L
D10AD04	ROACCUTANE	B	Isotretinoin - 0.05%	0.05%	Gel	932,627 L.L
L01ED01	XALKORI	B	Crizotinib - 200mg	200mg	Capsule	347,644,061 L.L
M01AB16	AIRTAL 100MG 20	B	Aceclofenac - 100mg	100mg	Tablet, film coated	471,689 L.L
N03AX09	LAMICTAL	B	Lamotrigine - 50mg	50mg	Tablet	1,753,895 L.L
P02CA01	VERMOX	B	Mebendazole - 500mg	500mg	Tablet	106,164 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 25mg	25mg	Tablet, film coated	75,701,015 L.L
D10AD06	AKLIEF	B	Trifarotene - 50mcg/g	50mcg/g	Cream	4,359,425 L.L
J07AL02	PREVENAR 20	B	Pneumococcal polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F,8, 9V,10A, 11A, 12F, 14, 15B, 18C, 19A, 19F,22F, 23F, 33F (2.2mcg) Pneumococcal polysaccharide for serotypes 6B (4.4mcg)Conjugated to CRM197 carrier protein (approximately 51mcg) adsorbed on aluminium phosphate (0.125mg aluminium) -		Injectable suspension	7,415,107 L.L
L01ED03	ALECENSA	B	Alectinib - 150mg	150mg	Capsule, hard	490,837,809 L.L
N03AX11	TOPAMAX 25	B	Topiramate - 25mg	25mg	Tablet, film coated	858,715 L.L
P02CA01	VERMOX	B	Mebendazole - 100mg	100mg	Tablet	190,826 L.L
V03AC03	JADENU	B	Deferasirox - 180mg	180mg	Tablet, film coated	27,151,164 L.L
A08AA01	LOMAIRA	B	Phentermine Hydrochloride - 8mg	8mg	Tablet	6,138,673 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.25mcg	0.25mcg	Capsule	1,138,235 L.L
J07AL02	VAXNEUVANCE	B	Pneumococcal polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F, 9V,14, 18C, 19A, 19F, 22F, 23F,33F (2mcg) Pneumococcal polysaccharide for serotypes 6B (4.4mcg) Conjugated to CRM197 carrier protein and adsorbed on aluminium phosphate adjuvant -		Injectable suspension	6,988,413 L.L
L01ED04	ALUNBRIG	B	Brigatinib - 30mg	30mg	Tablet, film coated	124,685,776 L.L
R05X	ACTISOUFRE	B	Sulfure de Sodium - 13mg, Saccharomyces Cerevisiae - 500mg		Solution	740,457 L.L
A08AA62	CONTRAVE	B	Naltrexone Hydrochloride - 8mg, Bupropion Hydrochloride - 90mg		Tablet, prolonged release	11,653,550 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.5mcg	0.5mcg	Capsule	943,377 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 50mg	50mg	Tablet, film coated	151,399,262 L.L
J07AP03	TYPHIM VI	B	Salmonella typhi polysaccharides - 0.025mg/0.5ml	0.025mg/0.5ml	Injectable solution	1,118,077 L.L
L01ED04	ALUNBRIG	B	Brigatinib - 90mg	90mg	Tablet, film coated	374,059,747 L.L
R05X	FERVEX CHILDREN SUGAR FREE	B	Paracetamol - 280mg, Ascorbic acid - 100mg, Pheniramine maleate - 10mg		Granules for solution	425,998 L.L
A08AB01	XENICAL	B	Orlistat - 120mg	120mg	Capsule	4,036,903 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.5mcg	0.5mcg	Capsule	942,034 L.L
C09CA06	ATACAND	B	Candesartan cilexetil - 8mg	8mg	Tablet	526,786 L.L
J07AP03	TYPHIBEV TYPHOID CONJUGATED VACCINE (MONOVALENT)	B	Salmonella typhi polysaccharides Vi purified - 25mcg of Vi-PS2/0.5ml		Injectable suspension	4,020,777 L.L

Laws and Regulations